Stonnington Group’s Eli Lilly LLY Stock Holding History

Stonnington Group’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	$1.68M	Sell	4,465 -3,001	-40%	-$1.01M	0.44%	61
2022 Q4	$2.63M	Buy	7,466 +1,006	+16%	+$357K	0.73%	37
2022 Q3	$2.13M	Buy	6,460 +1,075	+20%	+$341K	0.6%	47
2022 Q2	$1.77M	Buy	5,385 +3,175	+144%	+$953K	0.47%	59
2022 Q1	$683K	Sell	2,210 -425	-16%	-$109K	0.16%	127
2021 Q4	$691K	Buy	2,635 +535	+25%	+$136K	0.15%	137
2021 Q3	$491K	Sell	2,100 -127	-6%	-$31.3K	0.11%	169
2021 Q2	$528K	Sell	2,227 -3,050	-58%	-$613K	0.12%	169
2021 Q1	$1.02M	Buy	+5,277	New	+$1.03M	0.25%	105

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Stonnington Group's LLY Position: Q1 2023 in Review

Stonnington Group reduced its Eli Lilly (LLY) stake by 40% in Q1 2023, selling an estimated $1.01M and leaving 4,465 shares worth $1.68M. The position accounts for 0.44% of the portfolio, ranked #61.

Stonnington Group first reported a position in LLY in Q1 2021 and has held it in 9 quarters since. The position peaked at $2.63M in Q4 2022. 2,614 funds tracked by Wall St. Rank hold LLY as of Q1 2023.

Stonnington Group held 4,465 shares of Eli Lilly worth $1.68M as of Q1 2023.
Stonnington Group sold 3,001 Eli Lilly shares in Q1 2023, an estimated $1.01M.
Eli Lilly made up 0.44% of Stonnington Group's portfolio in Q1 2023, its #61 holding.
Stonnington Group first reported a position in Eli Lilly in Q1 2021 and has held it in 9 quarters since.
Stonnington Group's Eli Lilly position peaked at $2.63M in Q4 2022.
2,614 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2023.

Based on Stonnington Group's 13F filing for Q1 2023, filed 14 Apr 2023.